[CAS NO. 195514-63-7]  Rimiducid (AP1903)

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [195514-63-7]

Catalog
SLK-S9726
Brand
Selleck
CAS
195514-63-7

DESCRIPTION [195514-63-7]

Overview

MDLMFCD25976784
Molecular Weight1411.63
Molecular FormulaC78H98N4O20
SMILESO=C(N1[C@@H](CCCC1)C(O[C@@H](C2=CC(OCC(NCCNC(COC3=CC([C@@H](CCC4=CC(OC)=C(C=C4)OC)OC([C@H]5N(CCCC5)C([C@H](C6=CC(OC)=C(C(OC)=C6)OC)CC)=O)=O)=CC=C3)=O)=O)=CC=C2)CCC7=CC(OC)=C(C=C7)OC)=O)[C@H](C8=CC(OC)=C(C(OC)=C8)OC)CC

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM0.7084 mL3.5420 mL7.0840 mL
5 mM0.1417 mL0.7084 mL1.4168 mL
10 mM0.0708 mL0.3542 mL0.7084 mL
50 mM0.0142 mL0.0708 mL0.1417 mL

Description

Rimiducid (AP1903) is a chemical protein dimerizer and binds tightly to the target while binding minimally to the abundant natural FKBP. Rimiducid elicites potent and dose-dependent apoptosis of cells in culture expressing dimerizer-dependent Fas constructs, with an EC50 of ≈0.1 nM.

Targets

FKBP fusion protein [1]

In vitro

Rimiducid (AP1903) induces effective and dose-dependent apoptosis in the culture expressing dimer-dependent Fas constructors, indicating that Rimiducid causes the activation of Fas signaling without interference from endogenous FKBP.[2]